I am an experienced scientist and consultant specializing in lipid-based drug delivery systems, with a focus on lipid nanoparticles (LNPs) and liposomes. My expertise spans formulation development, biomarker discovery, in vitro and in vivo validation, process development, and manufacturing. I have contributed to advancing preclinical drug delivery technologies for cancer, vaccines, gene editing, diabetes, and obesity.I completed my postdoctoral research at Vanderbilt University and hold a Ph.D. in Pharmaceutical Sciences from the University of British Columbia. I earned my Bachelor of Science in Biopharmaceutical Sciences, with a specialization in medicinal chemistry, from the University of Ottawa.